AMPHASTAR PHARMACEUTICALS INC (AMPH)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jack Yongfeng Zhang Chief Executive Officer, President, Chief Scientific Officer and Director | 2025 | $950,911 | $329,747 | $3,301,981 | $3,302,024 | $361,000 | $63,687 | $8,309,350 |
| 2024 | $915,308 | $317,078 | $3,001,991 | $3,002,025 | $444,000 | $54,357 | $7,734,759 | |
| 2023 | $898,000 | $310,847 | $2,858,985 | $2,859,027 | $736,000 | $59,909 | $7,722,768 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Mary Ziping Luo Chief Operating Officer, Chief Scientist and Chairman | 2025 | $775,120 | $288,923 | $1,391,976 | $1,392,030 | $128,000 | $55,029 | $4,031,078 |
| 2024 | $746,038 | $314,723 | $1,265,495 | $1,265,512 | $163,000 | $43,930 | $3,798,698 | |
| 2023 | $732,002 | $309,632 | $1,204,994 | $1,205,010 | $280,000 | $43,009 | $3,774,647 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| William J. Peters Chief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director | 2025 | $649,846 | $370,308 | $1,043,982 | $1,044,022 | $73,000 | $57,524 | $3,238,682 |
| 2024 | $625,527 | $292,616 | $907,459 | $907,546 | $121,000 | $56,713 | $2,910,861 | |
| 2023 | $612,579 | $283,232 | $840,485 | $840,529 | $261,000 | $55,475 | $2,893,300 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Rong Zhou Senior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | 2025 | $717,587 | $280,475 | $701,500 | $701,513 | $98,000 | $43,559 | $2,542,634 |
| 2024 | $564,476 | $235,076 | $584,480 | $584,525 | $116,000 | $43,361 | $2,127,918 | |
| 2023 | $542,334 | $209,876 | $531,482 | $531,533 | $167,000 | $43,087 | $2,025,312 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jacob Liawiaidiewi Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S. | 2025 | $499,909 | $265,200 | $591,979 | $592,026 | $47,000 | $41,742 | $2,037,856 |
| 2024 | $480,789 | $220,375 | $501,997 | $502,025 | $75,000 | $41,576 | $1,821,762 | |
| 2023 | $495,545 | $195,851 | $447,978 | $448,023 | $148,000 | $40,702 | $1,776,099 |